Ian M. Adcock
- Basic science: Epigenetic programming and the respiratory systemBy Andrew L. Durham and Ian M. AdcockAndrew L. DurhamAirways Disease Section, National Heart & Lung Institute, Imperial College London, London, UKIan M. AdcockAirways Disease Section, National Heart & Lung Institute, Imperial College London, London, UK
- Application of ’omics technologies to biomarker discovery in inflammatory lung diseasesBy Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Dominic Burg, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanović and the U-BIOPRED Study GroupCraig E. Wheelock1Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm2Centre for Allergy Research, Karolinska Institutet, StockholmVictoria M. Goss3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonDavid Balgoma1Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm2Centre for Allergy Research, Karolinska Institutet, StockholmBen Nicholas3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonJoost Brandsma3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonPaul J. Skipp4Centre for Biological Sciences, University of Southampton Faculty of Natural and Environmental Sciences and Centre for Proteomic Research, SouthamptonStuart Snowden1Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm2Centre for Allergy Research, Karolinska Institutet, StockholmDominic Burg3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton4Centre for Biological Sciences, University of Southampton Faculty of Natural and Environmental Sciences and Centre for Proteomic Research, SouthamptonArnaldo D'Amico5Dept of Electronic Engineering, University of Rome "Tor Vergata", RomeIldiko Horvath6Dept of Pulmonology, Semmelweis University, Budapest, HungaryAmphun Chaiboonchoe7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceHassan Ahmed7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceStéphane Ballereau7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceChristos Rossios8Airways Disease, National Heart and Lung Institute, Imperial College London, LondonKian Fan Chung8Airways Disease, National Heart and Lung Institute, Imperial College London, LondonPaolo Montuschi9Dept of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, ItalyStephen J. Fowler10University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Respiratory Research Group, Education and Research Centre, Wythenshawe Hospital, ManchesterIan M. Adcock8Airways Disease, National Heart and Lung Institute, Imperial College London, LondonAnthony D. Postle3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, SouthamptonSven-Erik Dahlén2Centre for Allergy Research, Karolinska Institutet, Stockholm11Unit for Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenAnthony Rowe12Janssen Research and Development Ltd, High Wycombe, UKPeter J. Sterk13Dept of Respiratory Medicine, Academic Medical Center University of Amsterdam, Amsterdam, The NetherlandsCharles Auffray7CNRS Institute of Biological Sciences, European Institute for Systems Biology and Medicine, Claude Bernard University, Lyon, FranceRatko Djukanović3Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton
- Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glandsBy Gaetano Caramori, Paolo Casolari, Elvira Garofano, Marco Contoli, Giulia Gnesini, Anna Padovani, Kian Fan Chung, Peter J. Barnes, Ian M. Adcock and Alberto PapiGaetano Caramori1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyPaolo Casolari1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyElvira Garofano1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyMarco Contoli1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyGiulia Gnesini1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyAnna Padovani1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, ItalyKian Fan Chung2Airways Disease Section, NHLI, Imperial College London, London, United KingdomPeter J. Barnes2Airways Disease Section, NHLI, Imperial College London, London, United KingdomIan M. Adcock2Airways Disease Section, NHLI, Imperial College London, London, United KingdomAlberto Papi1Sezione di Malattie dell'Apparato Respiratorio, University of Ferrara, Ferrara, Italy
- Coordinate regulation of IL-4 and IL-13 expression in human T cells: 3C analysis for DNA loopingBy Xin Yao, Wei Song, Wangjian Zha, Peter J. Barnes, Ian M. Adcock and Andrew L. DurhamXin Yao1Department of Respiratory Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaWei Song1Department of Respiratory Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaWangjian Zha1Department of Respiratory Disease, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaPeter J. Barnes2National Heart and Lung Institute, Imperial College London, London, United KingdomIan M. Adcock2National Heart and Lung Institute, Imperial College London, London, United KingdomAndrew L. Durham2National Heart and Lung Institute, Imperial College London, London, United Kingdom
- IL-33 has a nuclear distribution and is not increased in peripheral lung of COPD patientsBy Gaetano Caramori, Paolo Casolari, Anna Padovani, Elvira Garofano, Marco Contoli, Kian Fan Chung, Ian M. Adcock and Alberto PapiGaetano Caramori1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyPaolo Casolari1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyAnna Padovani1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyElvira Garofano1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyMarco Contoli1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, ItalyKian Fan Chung2Airways Disease Section, NHLI, Imperial College London, London, United KingdomIan M. Adcock2Airways Disease Section, NHLI, Imperial College London, London, United KingdomAlberto Papi1Centro di Ricerca su Asma e BPCO, University of Ferrara, Ferrara, Italy
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaBy Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecker, Louis-Philippe Boulet, Christopher Brightling, Pascal Chanez, Sven-Erik Dahlen, Ratko Djukanovic, Urs Frey, Mina Gaga, Peter Gibson, Qutayba Hamid, Nizar N. Jajour, Thais Mauad, Ronald L. Sorkness and W. Gerald TeagueKian Fan Chung1National Heart and Lung Institute, Imperial College, London2Biomedical Research Unit, Royal Brompton Hospital, London21Both authors contributed equallySally E. Wenzel3Dept of Medicine, University of Pittsburgh, Pittsburgh, PA21Both authors contributed equallyJan L. Brozek4Dept of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, OntarioAndrew Bush1National Heart and Lung Institute, Imperial College, London2Biomedical Research Unit, Royal Brompton Hospital, LondonMario Castro5Dept of Medicine, Washington University, St Louis, MOPeter J. Sterk6Dept of Respiratory Medicine, Academic Medical Centre, Amsterdam, The NetherlandsIan M. Adcock1National Heart and Lung Institute, Imperial College, LondonEric D. Bateman7Lung Institute, University of Cape Town, Cape Town, South AfricaElisabeth H. Bel6Dept of Respiratory Medicine, Academic Medical Centre, Amsterdam, The NetherlandsEugene R. Bleecker8Dept of Medicine, Wake Forest University, Winston Salem, NCLouis-Philippe Boulet9Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QuebecChristopher Brightling10Institute for Lung Health, Leicester University, LeicesterPascal Chanez11Departement des Maladies Respiratoires, Marseille Universite, Marseille, FranceSven-Erik Dahlen12Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenRatko Djukanovic13Southampton NIHR Respiratory Biomedical Research Unit, University of Southampton School of Medicine and Southampton General Hospital, Southampton UKUrs Frey14University Children’s Hospital (UKBB), University of Basel, Basel, SwitzerlandMina Gaga15th, Athens, GreecePeter Gibson16Hunter Medical Research Institute, John Hunter Hospital, Newcastle, AustraliaQutayba Hamid17Meakins-Christie Laboratories, McGill University, Montreal, Quebec, CanadaNizar N. Jajour18Dept of Medicine, University of Wisconsin, Madison, WIThais Mauad19Dept of Pathology, University Medical School, Sao Paulo, BrazilRonald L. Sorkness18Dept of Medicine, University of Wisconsin, Madison, WIW. Gerald Teague20Division of Respiratory Medicine, Allergy, and Immunology, Dept of Paediatrics, University of Virginia School of Medicine, VA, USA
- Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPDBy Paul A. Kirkham, Matthew Whiteman, Paul G. Winyard, Gaetano Caramori, Fabiana Gordon, Paul A. Ford, Peter J. Barnes, Ian M. Adcock and Kian Fan ChungPaul A. Kirkham1Airways Diseases, National Heart and Lung Institute, Imperial College London, London2Dept of Biomedical Sciences, University of Wolverhampton, WolverhamptonMatthew Whiteman3University of Exeter Medical School, ExeterPaul G. Winyard3University of Exeter Medical School, ExeterGaetano Caramori4Dipartimento di Scienze Mediche, Centro Interdipartimentale per lo Studio delle Malattie Infiammatorie delle Vie Aeree e Patologie Fumo-correlate (CEMICEF), Sezione di Medicina Interna e Cardiorespiratoria, Università di Ferrara, Ferrara, ItalyFabiana Gordon5Statistical Advisory Service, Imperial College London, London, UKPaul A. Ford1Airways Diseases, National Heart and Lung Institute, Imperial College London, LondonPeter J. Barnes1Airways Diseases, National Heart and Lung Institute, Imperial College London, LondonIan M. Adcock1Airways Diseases, National Heart and Lung Institute, Imperial College London, LondonKian Fan Chung1Airways Diseases, National Heart and Lung Institute, Imperial College London, London
- TLR7 and TLR9-activated inflammation is differentially regulated in asthmaBy Christos Rossios, David Gibeon, Patricia Macedo, Kian Fan Chung and Ian M. AdcockChristos Rossios1Airway Disease Section, National Heart and Lung Institute, London, United KingdomDavid Gibeon1Airway Disease Section, National Heart and Lung Institute, London, United KingdomPatricia Macedo1Airway Disease Section, National Heart and Lung Institute, London, United KingdomKian Fan Chung1Airway Disease Section, National Heart and Lung Institute, London, United KingdomIan M. Adcock1Airway Disease Section, National Heart and Lung Institute, London, United Kingdom
- Effect of oxidative stress on mitochondrial function in airway smooth muscle (ASM) cells from COPD patientsBy Charalambos Michaeloudes, Priyanka Narang, Coen H.C. Wiegman, Paul A. Kirkham, Kian Fan Chung and Ian M. AdcockCharalambos Michaeloudes1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomPriyanka Narang1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomCoen H.C. Wiegman1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomPaul A. Kirkham1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomKian Fan Chung1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomIan M. Adcock1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United Kingdom
- Application of ‘omics technologies to biomarker discovery in inflammatory lung diseasesBy Craig E. Wheelock, Victoria M. Goss, David Balgoma, Ben Nicholas, Joost Brandsma, Paul J. Skipp, Stuart Snowden, Arnaldo D'Amico, Ildiko Horvath, Amphun Chaiboonchoe, Hassan Ahmed, Stéphane Ballereau, Christos Rossios, Kian Fan Chung, Paolo Montuschi, Stephen J. Fowler, Ian M. Adcock, Anthony D. Postle, Sven-Erik Dahlén, Anthony Rowe, Peter J. Sterk, Charles Auffray, Ratko Djukanović and the U-BIOPRED Study GroupArticle | Published in 2012 in European Respiratory JournalCraig E. Wheelock*Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm, Sweden#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;Victoria M. Goss¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;David Balgoma*Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm, Sweden#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;Ben Nicholas¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;Joost Brandsma¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;Paul J. Skipp+Centre for Biological Sciences, University of Southampton Faculty of Natural and Environmental Sciences and Centre for Proteomic Research, Southampton, United Kingdom;Stuart Snowden*Dept of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institutet, Stockholm, Sweden#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;Arnaldo D'Amico§Dept of Electronic Engineering, University of Rome "Tor Vergata", Rome, Italy;Ildiko HorvathfDept of Pulmonology, Semmelweis University, Budapest Dios arok 1/C, H-1125, Hungary;Amphun Chaiboonchoe**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Hassan Ahmed**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Stéphane Ballereau**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Christos Rossios##Airways Disease, National Heart & Lung Institute, Imperial College London, United Kingdom;Kian Fan Chung##Airways Disease, National Heart & Lung Institute, Imperial College London, United Kingdom;Paolo Montuschi¶¶Dept of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Rome, Italy;Stephen J. Fowler++Lecturer and Honorary Consultant in Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Respiratory Research Group, Education and Research Centre, Wythenshawe Hospital, Manchester, United Kingdom;Ian M. Adcock##Airways Disease, National Heart & Lung Institute, Imperial College London, United Kingdom;Anthony D. Postle¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;Sven-Erik Dahlén#Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden;§§Unit for Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, Sweden;Anthony RoweffJanssen Research and Development Ltd, High Wycombe, UKPeter J. Sterk***Dept of Respiratory Medicine, Academic Medical Center University of Amsterdam, Amsterdam, The NetherlandsCharles Auffray**CNRS Institute of Biological Sciences, European Institute for Systems Biology & Medicine, Claude Bernard University, Lyon, France;Ratko Djukanović¶Clinical and Experimental Sciences, University of Southampton Faculty of Medicine and NIHR Southampton Respiratory Biomedical Research Unit, Southampton, United Kingdom;
- Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPDBy Paul A. Kirkham, Matthew Whiteman, Paul G. Winyard, Gaetano Caramori, Fabiana Gordon, Paul A. Ford, Peter J. Barnes, Ian M. Adcock and Kian Fan ChungArticle | Published in 2014 in European Respiratory JournalPaul A. Kirkham1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,2Dept of Biomedical Sciences, University of Wolverhampton, Wolverhampton,Matthew Whiteman3University of Exeter Medical School, Exeter,Paul G. Winyard3University of Exeter Medical School, Exeter,Gaetano Caramori4Dipartimento di Scienze Mediche, Centro Interdipartimentale per lo Studio delle Malattie Infiammatorie delle Vie Aeree e Patologie Fumo-correlate (CEMICEF), Sezione di Medicina Interna e Cardiorespiratoria, Università di Ferrara, Ferrara, ItalyFabiana Gordon5Statistical Advisory Service, Imperial College London, London, UKPaul A. Ford1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,Peter J. Barnes1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,Ian M. Adcock1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,Kian Fan Chung1Airways Diseases, National Heart and Lung Institute, Imperial College London, London,
- “Education is the passport to the future”: enabling today’s medical teachers to prepare tomorrow’s respiratory health practitionersBy Sharon Mitchell, Konrad E. Bloch, Indre Butiene, Brendan G. Cooper, Irene Steenbruggen, Alanna Hare, Konstantinos Kostikas, Ian M. Adcock, James Paton, Monica Fletcher, Robin Stevenson, Gernot Rohde and Anita K. SimondsSharon Mitchell1European Respiratory Society, Lausanne, SwitzerlandKonrad E. Bloch2Pulmonary Division, University Hospital Zurich, Zurich, SwitzerlandIndre Butiene3Faculty of Health Science, Klaipeda University, Klaipeda, LithuaniaBrendan G. Cooper4Lung Function and Sleep, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, UKIrene Steenbruggen5Lung Function Laboratory, Isala Klinieken, Zwolle, The NetherlandsAlanna Hare6Sleep and Ventilation, Royal Brompton and Harefield NHS Foundation Trust, London, UKKonstantinos Kostikas72nd Respiratory Medicine Department, University of Athens Medical School, Athens, GreeceIan M. Adcock8Thoracic Medicine, National Heart and Lung Institute, Imperial College London, London, UKJames Paton9Royal Hospital for Sick Children, School of Medicine, College of Medical, Veterinary, and Life Sciences University of Glasgow, Glasgow, UKMonica Fletcher10Chair of European Lung Foundation, Education for Health, Warwick, UKRobin Stevenson11Editor-in-Chief of the Journal of European CMEGernot Rohde12Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The NetherlandsAnita K. Simonds13Academic Department of Sleep and Breathing, Royal Brompton Hospital, London, UK
- Corticosteroid insensitivity in airway smooth muscle cells from severe asthma is dependent on stimulus and cytokine productBy Christos Rossios, David Gibeon, Kian Fan Chung, Ian M. Adcock and U-BIOPRED study groupChristos Rossios1Airway Disease, National Heart and Lung Institute, London, United Kingdom2Royal Brompton Hospital, NIHR BioMedical Research Unit, London, United KingdomDavid Gibeon1Airway Disease, National Heart and Lung Institute, London, United Kingdom2Royal Brompton Hospital, NIHR BioMedical Research Unit, London, United KingdomKian Fan Chung1Airway Disease, National Heart and Lung Institute, London, United Kingdom2Royal Brompton Hospital, NIHR BioMedical Research Unit, London, United KingdomIan M. Adcock1Airway Disease, National Heart and Lung Institute, London, United Kingdom2Royal Brompton Hospital, NIHR BioMedical Research Unit, London, United KingdomU-BIOPRED study group1Airway Disease, National Heart and Lung Institute, London, United Kingdom
- Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohortBy Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel, Charles Auffray, Chris H. Compton, Hans Bisgaard, Enrica Bucchioni, Massimo Caruso, Pascal Chanez, Barbro Dahlén, Sven-Erik Dahlen, Kerry Dyson, Urs Frey, Thomas Geiser, Maria Gerhardsson de Verdier, David Gibeon, Yi-ke Guo, Simone Hashimoto, Gunilla Hedlin, Elizabeth Jeyasingham, Pieter-Paul W. Hekking, Tim Higenbottam, Ildikó Horváth, Alan J. Knox, Norbert Krug, Veit J. Erpenbeck, Lars X. Larsson, Nikos Lazarinis, John G. Matthews, Roelinde Middelveld, Paolo Montuschi, Jacek Musial, David Myles, Laurie Pahus, Thomas Sandström, Wolfgang Seibold, Florian Singer, Karin Strandberg, Jorgen Vestbo, Nadja Vissing, Christophe von Garnier, Ian M. Adcock, Scott Wagers, Anthony Rowe, Peter Howarth, Ariane H. Wagener, Ratko Djukanovic, Peter J. Sterk and Kian Fan ChungArticle | Published in 2015 in European Respiratory JournalDominick E. Shaw1Respiratory Research Unit, University of Nottingham, Nottingham, UK44Joint first authorsAna R. Sousa2Respiratory Therapeutic Unit, GSK, Stockley Park, UK44Joint first authorsStephen J. Fowler3Respiratory and Allergy Research Group, University of Manchester, Manchester, UKLouise J. Fleming4National Heart and Lung Institute, Imperial College, London, UKGraham Roberts5NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, Southampton, UK6Faculty of Medicine, University of Southampton, Southampton, UK7The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UKJulie Corfield8AstraZeneca R&D, Mölndal, Sweden9Areteva R&D, Nottingham, UKIoannis Pandis10Data Science Institute, South Kensington Campus, Imperial College London, London, UKAruna T. Bansal11Acclarogen Ltd, St John's Innovation Centre, Cambridge, UKElisabeth H. Bel12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsCharles Auffray13European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, FranceChris H. Compton2Respiratory Therapeutic Unit, GSK, Stockley Park, UKHans Bisgaard14Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkEnrica Bucchioni15Chiesi Pharmacueticals SPA, Parma, ItalyMassimo Caruso16Dept of Clinical and Experimental Medicine Hospital University, University of Catania, Catania, ItalyPascal Chanez17Département des Maladies Respiratoires, Laboratoire d'immunologie, Aix Marseille Université Marseille, Marseille, FranceBarbro Dahlén18Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, SwedenSven-Erik Dahlen19The Centre for Allergy Research, The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenKerry Dyson20CROMSOURCE, Stirling, UKUrs Frey21University Children's Hospital Basel, Basel, SwitzerlandThomas Geiser22University Hospital Bern, Bern, SwitzerlandMaria Gerhardsson de Verdier8AstraZeneca R&D, Mölndal, SwedenDavid Gibeon4National Heart and Lung Institute, Imperial College, London, UKYi-ke Guo10Data Science Institute, South Kensington Campus, Imperial College London, London, UKSimone Hashimoto12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsGunilla Hedlin23Dept of Women's and Children's Health and Center for Allergy Research, Karolinska Institutet, Stockholm, SwedenElizabeth Jeyasingham24UK Clinical Operations, GSK, Stockley Park, UKPieter-Paul W. Hekking12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsTim Higenbottam25Allergy Therapeutics, West Sussex, UKIldikó Horváth26Dept of Pulmonology, Semmelweis University, Budapest, HungaryAlan J. Knox1Respiratory Research Unit, University of Nottingham, Nottingham, UKNorbert Krug27Fraunhofer Institute for Toxicology and Experimental Medicine Hannover, Hannover, GermanyVeit J. Erpenbeck28Translational Medicine - Respiratory Profiling, Novartis Institutes for BioMedical Research, Basel, SwitzerlandLars X. Larsson8AstraZeneca R&D, Mölndal, SwedenNikos Lazarinis18Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, SwedenJohn G. Matthews29Respiratory and Allergic Diseases, Product Development Immunology, Genentech, San Francisco, CA, USARoelinde Middelveld20CROMSOURCE, Stirling, UKPaolo Montuschi30Faculty of Medicine, Catholic University of the Sacred Heart, Rome, ItalyJacek Musial31Dept of Medicine, Jagiellonian University Medical College, Krakow, PolandDavid Myles32Respiratory Therapy Area Unit, GlaxoSmithKline, Stevenage, UKLaurie Pahus33Assistance publique des Hôpitaux de Marseille, Hôpital NORD, Clinique des bronches, allergies et sommeil, Marseille, FranceThomas Sandström34Dept of Medicine, Dept of Public Health and Clinical Medicine Respiratory Medicine Unit, Umeå University, Umeå, SwedenWolfgang Seibold35Boehringer Ingelheim Pharma GmbH & Co., Ingelheim, GermanyFlorian Singer36University Children's Hospital Zurich, Zurich, SwitzerlandKarin Strandberg18Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, SwedenJorgen Vestbo37Respiratory Research Group, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UKNadja Vissing38The Danish Pediatric Asthma Center, University of Copenhagen, Copenhagen, DenmarkChristophe von Garnier22University Hospital Bern, Bern, Switzerland39Tiefenau Hospital, Bern, SwitzerlandIan M. Adcock4National Heart and Lung Institute, Imperial College, London, UK40Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, UKScott Wagers41BioSci Consulting, Maasmechelen, BelgiumAnthony Rowe42Janssen Research and Development Ltd, High Wycombe, UKPeter Howarth43NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UKAriane H. Wagener12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsRatko Djukanovic43NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UKPeter J. Sterk12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands45Joint last authorsKian Fan Chung4National Heart and Lung Institute, Imperial College, London, UK40Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, UK45Joint last authors
- Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohortBy Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel, Charles Auffray, Chris H. Compton, Hans Bisgaard, Enrica Bucchioni, Massimo Caruso, Pascal Chanez, Barbro Dahlén, Sven-Erik Dahlen, Kerry Dyson, Urs Frey, Thomas Geiser, Maria Gerhardsson de Verdier, David Gibeon, Yi-ke Guo, Simone Hashimoto, Gunilla Hedlin, Elizabeth Jeyasingham, Pieter-Paul W. Hekking, Tim Higenbottam, Ildikó Horváth, Alan J. Knox, Norbert Krug, Veit J. Erpenbeck, Lars X. Larsson, Nikos Lazarinis, John G. Matthews, Roelinde Middelveld, Paolo Montuschi, Jacek Musial, David Myles, Laurie Pahus, Thomas Sandström, Wolfgang Seibold, Florian Singer, Karin Strandberg, Jorgen Vestbo, Nadja Vissing, Christophe von Garnier, Ian M. Adcock, Scott Wagers, Anthony Rowe, Peter Howarth, Ariane H. Wagener, Ratko Djukanovic, Peter J. Sterk and Kian Fan ChungDominick E. Shaw1Respiratory Research Unit, University of Nottingham, Nottingham, UK44Joint first authorsAna R. Sousa2Respiratory Therapeutic Unit, GSK, Stockley Park, UK44Joint first authorsStephen J. Fowler3Respiratory and Allergy Research Group, University of Manchester, Manchester, UKLouise J. Fleming4National Heart and Lung Institute, Imperial College, London, UKGraham Roberts5NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, Southampton, UK6Faculty of Medicine, University of Southampton, Southampton, UK7The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Isle of Wight, UKJulie Corfield8AstraZeneca R&D, Mölndal, Sweden9Areteva R&D, Nottingham, UKIoannis Pandis10Data Science Institute, South Kensington Campus, Imperial College London, London, UKAruna T. Bansal11Acclarogen Ltd, St John's Innovation Centre, Cambridge, UKElisabeth H. Bel12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsCharles Auffray13European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, Lyon, FranceChris H. Compton2Respiratory Therapeutic Unit, GSK, Stockley Park, UKHans Bisgaard14Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkEnrica Bucchioni15Chiesi Pharmacueticals SPA, Parma, ItalyMassimo Caruso16Dept of Clinical and Experimental Medicine Hospital University, University of Catania, Catania, ItalyPascal Chanez17Département des Maladies Respiratoires, Laboratoire d'immunologie, Aix Marseille Université Marseille, Marseille, FranceBarbro Dahlén18Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, SwedenSven-Erik Dahlen19The Centre for Allergy Research, The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SwedenKerry Dyson20CROMSOURCE, Stirling, UKUrs Frey21University Children's Hospital Basel, Basel, SwitzerlandThomas Geiser22University Hospital Bern, Bern, SwitzerlandMaria Gerhardsson de Verdier8AstraZeneca R&D, Mölndal, SwedenDavid Gibeon4National Heart and Lung Institute, Imperial College, London, UKYi-ke Guo10Data Science Institute, South Kensington Campus, Imperial College London, London, UKSimone Hashimoto12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsGunilla Hedlin23Dept of Women's and Children's Health and Center for Allergy Research, Karolinska Institutet, Stockholm, SwedenElizabeth Jeyasingham24UK Clinical Operations, GSK, Stockley Park, UKPieter-Paul W. Hekking12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsTim Higenbottam25Allergy Therapeutics, West Sussex, UKIldikó Horváth26Dept of Pulmonology, Semmelweis University, Budapest, HungaryAlan J. Knox1Respiratory Research Unit, University of Nottingham, Nottingham, UKNorbert Krug27Fraunhofer Institute for Toxicology and Experimental Medicine Hannover, Hannover, GermanyVeit J. Erpenbeck28Translational Medicine - Respiratory Profiling, Novartis Institutes for BioMedical Research, Basel, SwitzerlandLars X. Larsson8AstraZeneca R&D, Mölndal, SwedenNikos Lazarinis18Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, SwedenJohn G. Matthews29Respiratory and Allergic Diseases, Product Development Immunology, Genentech, San Francisco, CA, USARoelinde Middelveld20CROMSOURCE, Stirling, UKPaolo Montuschi30Faculty of Medicine, Catholic University of the Sacred Heart, Rome, ItalyJacek Musial31Dept of Medicine, Jagiellonian University Medical College, Krakow, PolandDavid Myles32Respiratory Therapy Area Unit, GlaxoSmithKline, Stevenage, UKLaurie Pahus33Assistance publique des Hôpitaux de Marseille, Hôpital NORD, Clinique des bronches, allergies et sommeil, Marseille, FranceThomas Sandström34Dept of Medicine, Dept of Public Health and Clinical Medicine Respiratory Medicine Unit, Umeå University, Umeå, SwedenWolfgang Seibold35Boehringer Ingelheim Pharma GmbH & Co., Ingelheim, GermanyFlorian Singer36University Children's Hospital Zurich, Zurich, SwitzerlandKarin Strandberg18Lung/Allergy Clinic, Karolinska University Hospital Huddinge, Stockholm, SwedenJorgen Vestbo37Respiratory Research Group, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UKNadja Vissing38The Danish Pediatric Asthma Center, University of Copenhagen, Copenhagen, DenmarkChristophe von Garnier22University Hospital Bern, Bern, Switzerland39Tiefenau Hospital, Bern, SwitzerlandIan M. Adcock4National Heart and Lung Institute, Imperial College, London, UK40Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, UKScott Wagers41BioSci Consulting, Maasmechelen, BelgiumAnthony Rowe42Janssen Research and Development Ltd, High Wycombe, UKPeter Howarth43NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UKAriane H. Wagener12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The NetherlandsRatko Djukanovic43NIHR Southampton Respiratory Biomedical Research Unit, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UKPeter J. Sterk12Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands45Joint last authorsKian Fan Chung4National Heart and Lung Institute, Imperial College, London, UK40Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, UK45Joint last authors
- The first U-BIOPRED blood handprint of severe asthmaBy Bertrand De Meulder, Diane Lefaudeux, Jeanette Bigler, Matthew J. Loza, Craig E. Wheelock, Ana R. Sousa, Julie Corfield, Frédéric Baribaud, Charles Auffray, Dominic E. Shaw, Ildiko Horvath, Jacek Musial, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per S. Bakke, Florian Singer, Stephen J. Fowler, Sven-Erik Dahlen, Thomas Sandström, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock, Ratko Djukanovic and The U-BIOPRED Working GroupBertrand De Meulder1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone FranceDiane Lefaudeux1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone FranceJeanette Bigler2Amgen, Amgen, Seattle, United StatesMatthew J. Loza3Systems Pharmacology and Biomarkers, Janssen R&D, Springhouse, United StatesCraig E. Wheelock4Bioanalytical Chemistry Research Laboratory in Inflammatory Metabolomics, Karolinska Institutet, Stockholm, SwedenAna R. Sousa5Discovery Medicine, GlaxoSmithKline, Uxbridge, United KingdomJulie Corfield6Arateva, Arateva Ltd., Nottingham, United KingdomFrédéric Baribaud3Systems Pharmacology and Biomarkers, Janssen R&D, Springhouse, United StatesCharles Auffray1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone FranceDominic E. Shaw7Faculty of Medicine and Health Sciences, Nottingham University Hospital, Nottingham, United KingdomIldiko Horvath8Pulmonology, Semmelweis University, Budapest, HungaryJacek Musial9Allergy and Immunology, Jagiellonian University, Krakow, PolandPascal Chanez10Clinique des Bronches, Allergie et Sommeil, Université de la Méditerranée, Marseille, FranceNorbert Krug11Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute, Hannover, GermanyPaolo Montuschi12Pharmacology, Unniversità Cattolica del Sacro Cuore, Roma, ItalyPer S. Bakke13Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayFlorian Singer14Paediatric Respiratory Medicine, University Hospital, Inselpital, Bern, SwitzerlandStephen J. Fowler15Respiratory Research Group, University of Manchester, Manchester, United KingdomSven-Erik Dahlen16Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenThomas Sandström17Pulmonology, University Hospital, Umea, SwedenPeter J. Sterk18Pulmonology, Academisch Medisch Centrum, Amsterdam, NetherlandsKian Fan Chung19National Hearth & Lung Institute, Imperial College London, London, United KingdomIan M. Adcock19National Hearth & Lung Institute, Imperial College London, London, United KingdomRatko Djukanovic20National Institute for Health Research Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom1European Institute for Systems Biology and Medicine (EISBM), CNRS - ENS - UCBL Université de Lyon, Lyon, Rhone France
- MMP10 and MET as predictive classifiers of bronchial eosinophilic asthma in UBIOPREDBy Chih Hsi Kuo, Yike Guo, Ioannis Pandis, Stelios Pavlidis, Uruji Hoda, Christos Rossios, Anthony Rowe, Susan J. Wilson, Peter Howarth, Ratko Djukanovic, Matthew J. Loza, Fred Baribaud, Peter J. Sterk, Ian M. Adcock and Kian Fan ChungChih Hsi Kuo1Department of Computing, Imperial College London, London, United KingdomYike Guo1Department of Computing, Imperial College London, London, United KingdomIoannis Pandis1Department of Computing, Imperial College London, London, United KingdomStelios Pavlidis3Research and Development, Janssen Research & Development, LLC, High Wycombe, United KingdomUruji Hoda2The National Heart and Lung Institute, Imperil College London, London, United KingdomChristos Rossios2The National Heart and Lung Institute, Imperil College London, London, United KingdomAnthony Rowe3Research and Development, Janssen Research & Development, LLC, High Wycombe, United KingdomSusan J. Wilson4Faculty of Medicine, Southampton University, Southampton, United KingdomPeter Howarth4Faculty of Medicine, Southampton University, Southampton, United KingdomRatko Djukanovic4Faculty of Medicine, Southampton University, Southampton, United KingdomMatthew J. Loza3Research and Development, Janssen Research & Development, LLC, High Wycombe, United KingdomFred Baribaud3Research and Development, Janssen Research & Development, LLC, High Wycombe, United KingdomPeter J. Sterk5Faculty of Medicine, University of Amsterdam, Amsterdam, NetherlandsIan M. Adcock2The National Heart and Lung Institute, Imperil College London, London, United KingdomKian Fan Chung2The National Heart and Lung Institute, Imperil College London, London, United Kingdom
- The first U-BIOPRED sputum handprint of severe asthmaBy Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza, Marek Sanak, Ana R. Sousa, Julie Corfield, Frédéric Baribaud, Dominic E. Shaw, Ildiko Horvath, Jacek Musial, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per S. Bakke, Florian Singer, Stephen J. Fowler, Sven-Erik Dahlén, Thomas Sandström, Peter J. Sterk, Ratko Djukanovic, Kian Fan Chung, Ian M. Adcock, Charles Auffray and The U-BIOPRED Study GroupDiane Lefaudeux1EISBM, CNRS - ENS - UCBL, Lyon, FranceBertrand De Meulder1EISBM, CNRS - ENS - UCBL, Lyon, FranceMatthew J. Loza2Systems Pharmacology & Biomarkers, Janssen Research and Development, Springhouse, United StatesMarek Sanak3'Molecular Biology and Clinical Genetics' and 'Allergy and Immunology', Jagiellonian University Medical College, Krakow, PolandAna R. Sousa4Discovery Medicine, GlaxoSmithKline, Uxbridge, United KingdomJulie Corfield5Areteva, Arateva Ltd, Nottingham, United KingdomFrédéric Baribaud2Systems Pharmacology & Biomarkers, Janssen Research and Development, Springhouse, United StatesDominic E. Shaw6Faculty of Medicine & Health Sciences, Nottingham University Hospital, Nottingham, United KingdomIldiko Horvath7Pulmonology, Semmelweis University, Budapest, HungaryJacek Musial3'Molecular Biology and Clinical Genetics' and 'Allergy and Immunology', Jagiellonian University Medical College, Krakow, PolandPascal Chanez8Clinique des Bronches, Allergie et Sommeil, Université de la Méditerranée, Marseille, FranceNorbert Krug9Immunology, Allergology and Clinical Inhalation, Fraunhofer Institute, Hannover, GermanyPaolo Montuschi10Pharmacology, Università Cattolica del Sacro Cuore, Roma, ItalyPer S. Bakke11Thoracic Medicine, Haukeland University Hospital, Bergen, NorwayFlorian Singer12Pulmonology, University Hospital, Inselspital, Bern, SwitzerlandStephen J. Fowler13Respiratory Research Group, University of Manchester, Manchester, SwedenSven-Erik Dahlén14Experimental Asthma and Allergy Research, Karolinska Institutet, Stockholm, SwedenThomas Sandström15Pulmonology, University Hospital, Umea, SwedenPeter J. Sterk16Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsRatko Djukanovic17NHS Foundation Trust, University Hospital Southampton, Southampton, United KingdomKian Fan Chung18National Heart & Lung Institute, Imperial College London, London, United KingdomIan M. Adcock18National Heart & Lung Institute, Imperial College London, London, United KingdomCharles Auffray1EISBM, CNRS - ENS - UCBL, Lyon, France1EISBM, CNRS - ENS - UCBL, Lyon, France
- LSC Abstract – Rhinovirus infection induces NRF2 in monocytes but not in epithelial cells, via distinct intracellular pathwaysBy Andrew L. Durham, Joseph Footitt, Sarah Essilfie-Quaye, Aurica G. Telcian, Patrick Mallia, Kazuhiro Ito, Peter J. Barnes, Sebastian Johnston and Ian M. AdcockAndrew L. DurhamNational Heart and Lung Institute, Imperial College London, London, United KingdomJoseph FootittNational Heart and Lung Institute, Imperial College London, London, United KingdomSarah Essilfie-QuayeNational Heart and Lung Institute, Imperial College London, London, United KingdomAurica G. TelcianNational Heart and Lung Institute, Imperial College London, London, United KingdomPatrick MalliaNational Heart and Lung Institute, Imperial College London, London, United KingdomKazuhiro ItoNational Heart and Lung Institute, Imperial College London, London, United KingdomPeter J. BarnesNational Heart and Lung Institute, Imperial College London, London, United KingdomSebastian JohnstonNational Heart and Lung Institute, Imperial College London, London, United KingdomIan M. AdcockNational Heart and Lung Institute, Imperial College London, London, United Kingdom
- Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPREDBy Christos Rossios, Matt Loza, Stelios Pavlidis, Antony Rowe, Ratko Djukanovic, Fred Baribaud, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock and On Behalf of U-BIOPRED Study GroupChristos Rossios1Airway Disease, National Heart and Lung Institute, Imperial College, London, United KingdomMatt Loza2Janssen R&D, Janssen R&D, Greater Philadelphia Area, United StatesStelios Pavlidis3Janssen R&D, Janssen R&D, High Wycombe, United KingdomAntony Rowe3Janssen R&D, Janssen R&D, High Wycombe, United KingdomRatko Djukanovic4Faculty of Medicine, University of Southampton, Southampton, United KingdomFred Baribaud3Janssen R&D, Janssen R&D, High Wycombe, United KingdomPeter J. Sterk5Faculty of Medicine, University of Amsterdam, Amsterdam, NetherlandsKian Fan Chung1Airway Disease, National Heart and Lung Institute, Imperial College, London, United KingdomIan M. Adcock1Airway Disease, National Heart and Lung Institute, Imperial College, London, United Kingdom1Airway Disease, National Heart and Lung Institute, Imperial College, London, United Kingdom
- Mitochondrial reactive oxygen species and glycolysis in airway smooth muscle cell proliferation in COPDBy Charalambos Michaeloudes, Paul Kirkham, Ian M. Adcock and Kian Fan ChungCharalambos Michaeloudes1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomPaul Kirkham2Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, United KingdomIan M. Adcock1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United KingdomKian Fan Chung1National Heart and Lung Institute, Airway Disease Section, Imperial College London, London, United Kingdom
- Decreased breath excretion of redox active iron in COPD: a protective failure?By Sharon Mumby, Junpei Saito, Ian M. Adcock, Kian Fan Chung and Gregory J. QuinlanArticle | Published in 2015 in European Respiratory JournalSharon Mumby1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKJunpei Saito1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKIan M. Adcock1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKKian Fan Chung1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKGregory J. Quinlan2Vascular Biology Group, National Heart and Lung Institute, Imperial College London, London, UK
- The ERS Research Agency: the beginningBy Joan B. Soriano, James Paton, Fernando Martin Burrieza, Werner Bill, Carine Pannetier, Stefano Aliberti, Ian M. Adcock, Scott Wagers and Giovanni Battista MiglioriJoan B. Soriano1Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónoma de Madrid, Cátedra UAM-Linde, Madrid, SpainJames Paton2School of Medicine, University of Glasgow, Glasgow, UKFernando Martin Burrieza3ERS Executive Office, European Respiratory Society, Lausanne, SwitzerlandWerner Bill3ERS Executive Office, European Respiratory Society, Lausanne, SwitzerlandCarine Pannetier4ERS Science and Education, European Respiratory Society, Lausanne, SwitzerlandStefano Aliberti5School of Medicine and Surgery, University of Milan Bicocca, Milano, ItalyIan M. Adcock6Cell and Molecular Biology, Airways Disease Section, National Heart and Lung Institute Faculty of Medicine, Imperial College London, London, UKScott Wagers7BioSci Consulting, Maasmechelen, BelgiumGiovanni Battista Migliori8WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Decreased breath excretion of redox active iron in COPD: a protective failure?By Sharon Mumby, Junpei Saito, Ian M. Adcock, Kian Fan Chung and Gregory J. QuinlanSharon Mumby1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKJunpei Saito1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKIan M. Adcock1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKKian Fan Chung1Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UKGregory J. Quinlan2Vascular Biology Group, National Heart and Lung Institute, Imperial College London, London, UK
- Severe AsthmaEdited by Kian Fan Chung, Elliot Israel and Peter G. GibsonBook | Published in 2019DOI: 10.1183/2312508X.erm8419ISBN (electronic): 978-1-84984-104-7Kian Fan ChungElliot Israel
- Supporting Tobacco CessationEdited by Sofia Belo Ravara, Elif Dağli, Paraskevi Katsaounou, Keir E. Lewis and Charlotta PisingerBook | Published in 2021DOI: 10.1183/2312508X.erm9021ISBN (electronic): 978-1-84984-128-3Sofia Belo RavaraElif DağliParaskevi KatsaounouKeir E. Lewis
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.